InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.005

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Re-instatement to Official Quotation Imminent 14 May 2024 8:53AM $0.074 $0.005 fallen by 93.24%
$4 Change of Company Secretary 13 May 2024 10:09AM $0.074 $0.005 fallen by 93.24%
$4 Notification of cessation of securities - IBX 10 May 2024 6:27PM $0.074 $0.005 fallen by 93.24%
$4 Appendix 4G and Corporate Governance Statement 10 May 2024 6:27PM $0.074 $0.005 fallen by 93.24%
$4 Proposed issue of securities - IBX 10 May 2024 6:26PM $0.074 $0.005 fallen by 93.24%
$4 2023 Annual Report to shareholders 10 May 2024 6:26PM $0.074 $0.005 fallen by 93.24%
$4 Final Director's Interest Notice 9 May 2024 5:48PM $0.074 $0.005 fallen by 93.24%
$4 Notice of Annual General Meeting/Proxy Form 3 May 2024 4:11PM $0.074 $0.005 fallen by 93.24%
$4 Director Resignation 3 May 2024 10:10AM $0.074 $0.005 fallen by 93.24%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 4:15PM $0.074 $0.005 fallen by 93.24%
$4 Suspension from Quotation 2 Apr 2024 9:38AM $0.074 $0.005 fallen by 93.24%
$4 Appendix 4E and Preliminary Final Report 29 Feb 2024 4:23PM $0.091 $0.005 fallen by 94.51%
$4 Imagion Business Update 28 Feb 2024 4:02PM $0.084 $0.005 fallen by 94.05%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 4:07PM $0.170 $0.005 fallen by 97.06%
$4 Final Director's Interest Notice - Dr. Isaac Bright 17 Jan 2024 10:44AM $0.220 $0.005 fallen by 97.73%
$4 Imagion Announces CEO Departure 15 Jan 2024 2:24PM $0.280 $0.005 fallen by 98.21%
$4 Dr. Isaac Bright Options, Appendix 3X, Appendix 3Y 22 Dec 2023 9:03AM $0.360 $0.005 fallen by 98.61%
$4 Notification regarding unquoted securities - IBX 22 Dec 2023 9:00AM $0.360 $0.005 fallen by 98.61%
$4 Imagion Announces Positive Results from Phase 1 Study 7 Dec 2023 8:21AM $0.345 $0.005 fallen by 98.55%
$4 Notification of cessation of securities - IBX 6 Dec 2023 8:21AM $0.325 $0.005 fallen by 98.46%
$4 Results of Meeting 13 Nov 2023 11:44AM $0.011 $0.005 fallen by 54.55%
$4 EGM Investor Presentation 13 Nov 2023 9:36AM $0.010 $0.005 fallen by 50%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2023 8:20AM $0.011 $0.005 fallen by 54.55%
$4 Bio Investor Forum Investor Presentation 18 Oct 2023 8:20AM $0.012 $0.005 fallen by 58.33%
$4 Phase 1 Study Closure and Preliminary Performance 18 Oct 2023 8:20AM $0.012 $0.005 fallen by 58.33%

201 - 225 of 695 results

Page 9 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.